Black Diamond Therapeutics (BDTX)

• Market cap: $152M
• 1 day: 0.75%
• 5 days: -1.84%
• 1 month: -33.42%
• 3 months: -15.77%
• 6 months: 11.72%
• Year to date: 24.77%
• 1 year: 1.14%
• 5 years: -92.26%
• 10 years: -93.24%
• Sector: Healthcare
• Industry: Biotechnology

About: Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Employees: 54